RESUMO
From February 1989 to January 1994, nine of 63 (14.3%) survivors of neonatal extracorporeal membrane oxygenation developed bilateral sensorineural hearing loss. Seven of nine children were tested and passed initial or repeat clinical auditory brainstem response evaluation completed before discharge from neonatal intensive care. Hearing loss was suspected and confirmed between 6-36 and 10-48 months of age, respectively. We recommend regular audiologic follow-up for these high-risk infants until bilateral thresholds for hearing can be obtained.
Assuntos
Oxigenação por Membrana Extracorpórea/efeitos adversos , Perda Auditiva Neurossensorial/etiologia , Potenciais Evocados Auditivos do Tronco Encefálico , Humanos , Hipóxia/terapia , Recém-NascidoRESUMO
Auditory brain-stem responses from 25 neonates treated with extracorporeal membrane oxygenation were compared with those of 11 control subjects. Results revealed no statistically significant differences for recorded responses, either between ears or between groups. We conclude that infants who receive extracorporeal membrane oxygenation, with or without carotid artery repair, are not at greater risk for auditory brain-stem dysfunction than similar infants who do not receive extracorporeal membrane oxygenation.
Assuntos
Potenciais Evocados Auditivos do Tronco Encefálico , Oxigenação por Membrana Extracorpórea , Recém-Nascido/fisiologia , Feminino , Humanos , MasculinoRESUMO
OBJECTIVE: This study aimed to determine the prevalence of sensorineural hearing loss (SNHL) in 2-5-year-old survivors with neonatal respiratory failure due to congenital diaphragmatic hernia (CDH) with or without the need for extracorporeal membrane oxygenation (ECMO). STUDY DESIGN: The study design was a prospective, multicenter, longitudinal outcome study of consecutively surviving neonates admitted to a single tertiary intensive care unit. SETTING: The study was conducted at four audiologic departments affiliated with tertiary-level intensive care follow-up programs. PATIENTS: Thirty-seven surviving children receiving neonatal intensive care from February 1989 through January 1995 for neonatal respiratory failure due to CDH were studied. Excluded were 15 children with early death and I child lost to follow-up. INTERVENTION: The initial treatment depended on the severity of neonatal respiratory failure: ECMO-treated (n=31, 20 survivors) (death before ECMO initiation, 2) and non-ECMO treated (n=20, 17 survivors, another survivor lost to follow-up). MAIN OUTCOME MEASURE: Early childhood audiologic test results were measured. RESULTS: Sensorineural hearing loss was found in almost 60% of subjects: ECMO-treated, 12 (60%) of 20; non-ECMO-treated, 10 (59%) of 17. Of the 22 children with SNHL, 16 had mild- to-moderate low-frequency sloping to moderate-to-severe high-frequency loss. Of the remaining, six had severe-to-profound loss at 500 Hz and above. Seventeen children had normal responses to sound as newborns or in infancy. Five children were not tested. Documented progression was found in nine children. Twenty children currently are using amplification, and 2 have had cochlear implantation. CONCLUSIONS: Of children with CDH in this area presenting early with severe neonatal respiratory failure, SNHL developed in 60% by 2-5 years of life. Ongoing monitoring of the hearing status of children with CDH is imperative.